Concert Infectious Disease: Dermatologic Testing (PDF)
Outpatient policy governing medical necessity coverage criteria for microscopy/peroxidase tests, fungal culture (presumptive and/or definitive), and culture-independent molecular (NAAT/PCR) tests for onychomycosis (nail fungal infection).
For Fungal Culture for Onychomycosis and Microscopy/Peroxidase Tests for Onychomycosis, reworded policy statements from 'may be considered medically necessary' to 'are considered medically necessary.'
Added 'Lab' to policy title and moved/adjusted CPT code table.
Corrected CPT code descriptions in CPT code table.
Coverage Summary
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.